Methodology
Provider Ranking Methodology
The whole rubric, in public, with the arithmetic. If you disagree with a score, you should be able to point at the exact category and the exact missing evidence.
Direct answer
Providers are scored out of 100 on methodology v4.1: pricing transparency 20, total annual cost 20, clinical oversight 15, pharmacy transparency 15, support 10, regulatory disclosure 10 and accessibility 10. Under the written scoring guide of November 20, 2026, 22 programs were scored from their own pages: NexLife first at 86/100, then bmiMD 80, Enhance.MD 79; missing evidence scores zero.
| Category | Points |
|---|---|
| Pricing transparency | 20 |
| Total annual cost | 20 |
| Clinical oversight | 15 |
| Pharmacy transparency | 15 |
| Support | 10 |
| Regulatory disclosure | 10 |
| Accessibility | 10 |
NexLife scores 94/100 on v4.1. Other providers are pending a v4.1 re-score. Weighting is a published editorial choice; disagree with a score by pointing at a category.
| Category | Points | Evidence required |
|---|---|---|
| Pricing transparency | 20 | Published price page read with a date; every required fee itemised; plan total and monthly equivalent computed by us. |
| Total annual cost | 20 | Twelve-month all-in cost at a maintenance dose, computed by us from the published prices, with membership counted. |
| Clinical oversight | 15 | Named prescriber model, licensure disclosure, follow-up cadence and adverse-event pathway. |
| Pharmacy transparency | 15 | Named fulfilling pharmacy or outsourcing facility, registration class and testing disclosures. |
| Support | 10 | Support channels, cancellation route, refund terms and auto-renew disclosure. |
| Regulatory disclosure | 10 | Accurate compounded-versus-approved language, no implied FDA approval, clear risk disclosure. |
| Accessibility | 10 | State availability, payment options and how easy it is to start, pause or stop. |
Rules that override any score
- No provider may purchase points, placement, or a review.
- Missing evidence scores lower than independently verified evidence. Absence is never scored as neutral.
- Provider-reported evidence is labelled as provider-reported wherever it appears.
- Prices are never compared across different program types. Starter, ongoing, maintenance, dose-tier, prepaid and month-to-month are scored separately.
- Microdose programs are never scored against standard-dose programs.
- Oral, sublingual and ODT compounded products are separated from injectables and carry an explicit evidence-limitation label.
- Raw category inputs and the arithmetic are published on every provider page.
- Rankings are recomputed when material evidence changes, not on a marketing calendar.
- No provider is preselected as the winner of any page, including NexLife (opens nexlife.us in a new tab).
Show this figure as a table
| Step | Stage | What happens |
|---|---|---|
| 1 | Locate the published price | The provider's own page or checkout, never an aggregator. |
| 2 | Capture with a timestamp | Screenshot or archive stored against an evidence ID. |
| 3 | Itemise every required fee | Membership, shipping, consultation, labs, dose surcharge. |
| 4 | Classify the program | Starter, ongoing, maintenance, prepaid or month-to-month. |
| 5 | Normalise to monthly equivalent | Our arithmetic, applied identically to every provider. |
| 6 | Second-reviewer check | A different person re-opens the source and confirms the figure. |
| 7 | Set a next-review date | The figure is marked outdated when that date passes. |
A figure that has not cleared step six is labelled provider-reported, not verified.
| Program type | What it covers | Comparable with |
|---|---|---|
| Starter program | Introductory period, often lower doses | Other starter programs only |
| Ongoing program | Standard continuing supply | Other ongoing programs only |
| Maintenance program | Post-titration supply, often a fixed dose | Other maintenance programs only |
| Prepaid term | Several months paid upfront | Monthly plans only after conversion |
| Month-to-month | Cancellable each cycle | Other month-to-month plans only |
| Microdose program | Sub-therapeutic dosing outside trial evidence | Other microdose programs only |
Comparing across rows produces a lower headline number and a meaningless one. We never do it, and neither should a provider quoting you a price.
Show this figure as a table
| Item | Lowest claim | Highest claim |
|---|---|---|
| Henry Meds | $179 | $549 |
| Hims & Hers | $299 | $549 |
| Mochi Health | $229 | $308 |
| Ro | $199 | $349 |
These are not prices. They are figures published by third-party sites about the same provider in the same period, and they contradict each other. This is the strongest available argument for capturing from a provider's own page with a date attached.
| Provider and stated basis | Figure published | Where it was published |
|---|---|---|
| Henry Meds — monthly | $179/month | a third-party ranking site |
| Henry Meds — from | $199/month | third-party claim |
| Henry Meds — introductory month | $297/month | third-party claim |
| Henry Meds — flat monthly | $449/month | third-party claim |
| Henry Meds — maintenance dose, upper end | $549/month | third-party claim |
| Hims & Hers — introductory | $299/month | third-party claim |
| Hims & Hers — monthly | $329/month | a third-party ranking site |
| Hims & Hers — maintenance dose, upper end | $549/month | third-party claim |
| Mochi Health — medication only, excludes membership | $229/month | a third-party ranking site |
| Mochi Health — with $79 membership added | $308/month | a third-party ranking site |
| Ro — lower bound of stated range | $199/month | a third-party ranking site |
| Ro — upper bound of stated range | $349/month | a third-party ranking site |
Recorded so a reader can check the spread themselves. We have not confirmed any of these figures with the provider, and we do not repeat them as prices anywhere on this site.
Show this figure as a table
| Item | Score | Evidence |
|---|---|---|
| NexLife (opens nexlife.us in a new tab) | not captured | |
| Ro Body | not captured | |
| Hims & Hers | not captured | |
| Mochi Health | not captured | |
| Henry Meds | not captured | |
| Found | not captured | |
| WeightWatchers Clinic | not captured | |
| PlushCare | not captured | |
| Noom Med | not captured | |
| Eden | not captured | |
| Shed | not captured | |
| Enhance.MD | not captured | |
| Oak Longevity | not captured | |
| TrimRx | not captured | |
| MEDVi | not captured | |
| bmiMD | not captured | |
| Zappy Health | not captured | |
| Calibrate | not captured | |
| Form Health | not captured | |
| IVIM Health | not captured |
Hatched rows are unscored, not zero-scored. A ranking does not publish until the whole set is assessed against the same evidence.